Academic literature on the topic 'CVM (cervicovaginal microbiota)'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'CVM (cervicovaginal microbiota).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "CVM (cervicovaginal microbiota)"

1

Onywera, Harris, Anna-Lise Williamson, Zizipho Z. A. Mbulawa, David Coetzee, and Tracy L. Meiring. "Factors associated with the composition and diversity of the cervical microbiota of reproductive-age Black South African women: a retrospective cross-sectional study." PeerJ 7 (August 15, 2019): e7488. http://dx.doi.org/10.7717/peerj.7488.

Full text
Abstract:
Background Lactobacillus spp. are common bacteria in the cervical and vaginal microbiota (CVM) and are thought to represent a “healthy” cervicovaginal state. Several studies have found an independent association between ethnicity/race and cervical and vaginal microbiota (CVM) composition. Women of sub-Saharan African descent appear to be significantly more likely to have non-Lactobacillus-dominated CVM compared to women of European descent. The factors contributing to these differences remain to be fully elucidated. The CVM of Black South African women and factors influencing their CVM remain understudied. In this study, we characterized the cervical microbiota of reproductive-age South African women and assessed the associations of these microbiota with participants’ metadata. Methods The cervical microbiota from cervical DNA of 62 reproductive-age women were profiled by Ion Torrent sequencing the V4 hypervariable region of the bacterial 16S ribosomal RNA (rRNA) gene and analyzed with the Quantitative Insights Into Microbial Ecology (QIIME), UPARSE, and metagenomeSeq tools. Associations between cervical microbiota and participants’ metadata were assessed using GraphPad Prism, R packages and an in-house script. Results The cervical microbiota clustered into three distinct community state types (CSTs): Lactobacillus iners-dominated cervical microbiota (CST I (38.7%, 24/62)), unclassified Lactobacillus-dominated cervical microbiota (CST II (4.8%, 3/62)), and diverse cervical microbiota (CST III (56.5%, 35/62)) with an array of heterogeneous bacteria, predominantly the bacterial vaginosis (BV)-associated Gardnerella, Prevotella, Sneathia, and Shuttleworthia. CST III was associated with BV (p = 0.001). Women in CST I were more likely to be on hormonal contraception, especially progestin-based, compared to women in CST III (odds ratio: 5.2 (95% CI [1.6–17.2]); p = 0.005). Women on hormonal contraception had a significantly lower alpha (Shannon indices: 0.9 (0.2–1.9) versus 2.3 (0.6–2.3); p = 0.025) and beta (permutational multivariate analysis of variance (PERMANOVA) pseudo-F statistic =4.31, p = 0.019) diversity compared to non-users. There was no significant difference in the alpha (Shannon indices: 1.0 (0.3–2.2) versus 1.9 (0.3–2.2); p = 0.483) and beta (PERMANOVA pseudo-F statistic = 0.89, p = 0.373) diversity in women with versus without human papillomavirus infection. Conclusions The majority of Black women in our study had non-Lactobacillus-dominated cervical microbiota. Additional studies are needed to examine whether such microbiota represent abnormal, intermediate or variant states of health. Lastly, the association of hormonal contraception with L. iners dominance requires further in-depth research to confirm this association, determine its biological mechanism and whether it has a beneficial effect on the cervicovaginal health.
APA, Harvard, Vancouver, ISO, and other styles
2

Onywera, Harris, Joseph Anejo-Okopi, Lamech M. Mwapagha, Javan Okendo, and Anna-Lise Williamson. "Predictive functional analysis reveals inferred features unique to cervicovaginal microbiota of African women with bacterial vaginosis and high-risk human papillomavirus infection." PLOS ONE 16, no. 6 (June 18, 2021): e0253218. http://dx.doi.org/10.1371/journal.pone.0253218.

Full text
Abstract:
Mounting evidence suggests that Lactobacillus species may not necessarily be the sine qua non of healthy cervicovaginal microbiota (CVM), especially among reproductive-age African women. A majority of African women have high-diversity non-Lactobacillus-dominated CVM whose bacterial functions remain poorly characterized. Functional profiling of the CVM is vital for investigating human host-microbiota interactions in health and disease. Here, we investigated the functional potential of L. iners-dominated and high-diversity non-Lactobacillus-dominated CVM of 75 African women with and without bacterial vaginosis (BV) and high-risk human papillomavirus (HR-HPV) infection. Functional contents were predicted using PICRUSt. Microbial taxonomic diversity, BV, and HR-HPV infection statuses were correlated with the inferred functional composition of the CVM. Differentially abundant inferred functional categories were identified using linear discriminant analysis (LDA) effect size (LEfSe) (p-value <0.05 and logarithmic LDA score >2.0). Of the 75 women, 56 (74.7%), 35 (46.7%), and 29 (38.7%) had high-diversity non-Lactobacillus-dominated CVM, BV, and HR-HPV infection, respectively. Alpha diversity of the inferred functional contents (as measured by Shannon diversity index) was significantly higher in women with high-diversity non-Lactobacillus-dominated CVM and BV than their respective counterparts (H statistic ≥11.5, q-value <0.001). Ordination of the predicted functional metagenome content (using Bray-Curtis distances) showed that the samples segregated according to the extent of microbial taxonomic diversity and BV (pseudo-F statistic ≥19.6, q-value = 0.001) but not HR-HPV status (pseudo-F statistic = 1.7, q-value = 0.159). LEfSe analysis of the inferred functional categories revealed that transport systems (including ABC transporters) and transcription factors were enriched in high-diversity CVM. Interestingly, transcription factors and sporulation functional categories were uniquely associated with high-diversity CVM, BV, and HR-HPV infection. Our predictive functional analysis reveals features unique to high-diversity CVM, BV and HR-HPV infections. Such features may represent important biomarkers of BV and HR-HPV infection. Our findings require proof-of-concept functional studies to examine the relevance of these potential biomarkers in women’s reproductive health and disease.
APA, Harvard, Vancouver, ISO, and other styles
3

Yang, Zhongzhou, Ye Zhang, Araceli Stubbe-Espejel, Yumei Zhao, Mengping Liu, Jianjun Li, Yanping Zhao, et al. "Vaginal microbiota and personal risk factors associated with HPV status conversion—A new approach to reduce the risk of cervical cancer?" PLOS ONE 17, no. 8 (August 9, 2022): e0270521. http://dx.doi.org/10.1371/journal.pone.0270521.

Full text
Abstract:
Vaginal microbiota (VMB) is associated with changes in Human papilloma virus (HPV) status, which consequently influences the risk of cervical cancer. This association was often confounded by personal risk factors. This pilot research aimed to explore the relationship between vaginal microbiota, personal risk factors and their interactions with HPV status conversion to identify the vaginal microbiota that was associated with HPV clearance under heterogeneous personal risk factors. A total of 38 women participated by self-collecting a cervicovaginal mucus (CVM) sample that was sent for metagenomics sequencing. Most of the participants also filled in personal risk factors questionnaire through an eHealth platform and authorized the use of their previous HPV genotyping results stored in this eHealth platform. Based on the two HPV results, the participants were grouped into three cohorts, namely HPV negative, HPV persistent infection, and HPV status conversion. The relative abundance of VMB and personal factors were compared among these three cohorts. A correlation investigation was performed between VMB and the significant personal factors to characterize a robustness of the panel for HPV status change using R programming. At baseline, 12 participants were HPV-negative, and 22 were HPV-positive. Within one year, 18 women remained HPV-positive, 12 were HPV-negative and 4 participants showed HPV clearance. The factors in the eHealth questionnaire were systematically evaluated which identified several factors significantly associated with persistent HPV infection, including age, salary, history of reproductive tract infection, and the total number of sexual partners. Concurrent vaginal microbiome samples suggest that a candidate biomarker panel consisting of Lactobacillus gasseri, Streptococcus agalactiae, and Timona prevotella bacteria, which may be associated with HPV clearance. This pilot study indicates a stable HPV status-related vaginal microbe environment. To establish a robust biomarker panel for clinical use, larger cohorts will be recruited into follow-up studies.
APA, Harvard, Vancouver, ISO, and other styles
4

Cheu, Ryan K., Andrew T. Gustin, Christina Lee, Luca Schifanella, Charlene J. Miller, Avie Ha, Casey Kim, et al. "Impact of vaginal microbiome communities on HIV antiretroviral-based pre-exposure prophylaxis (PrEP) drug metabolism." PLOS Pathogens 16, no. 12 (December 3, 2020): e1009024. http://dx.doi.org/10.1371/journal.ppat.1009024.

Full text
Abstract:
Despite the efficacy of antiretroviral-based pre-exposure prophylactics (PrEP) in men who have sex with men, studies in women have produced widely varying outcomes. Recent evidence demonstrates that vaginal microbial communities are associated with increased HIV acquisition risk and may impact PrEP efficacy. Here, we investigate the mechanisms underlying how vaginal bacteria alter PrEP drug levels and impact HIV infection rates ex vivo. Using cervicovaginal lavages (CVLs) from women with or without bacterial vaginosis (BV), we identified microbial metabolism of PrEP drugs in BV samples through LC-MS/MS analysis of soluble drug levels and metabolite formation in dual T-cell cultures. CVL samples were assessed for microbiome analysis using sequencing of bacterial 16S rRNA genes. We also observed non-Lactobacillus bacteria that are associated with BV may potentially impact PrEP efficacy through increased HIV infection rates in co-cultures containing Lactobacillus or BV bacteria, PrEP drugs, CEM-GFP cells, and HIV-1LAI virus. Finally, we used these data to develop a novel predictive mathematical simulation modeling system to predict these drug interactions for future trials. These studies demonstrate how dysbiotic vaginal microbiota may impact PrEP drugs and provides evidence linking vaginal bacteria to PrEP efficacy in women.
APA, Harvard, Vancouver, ISO, and other styles
5

Ivanov, Mikhail K., Evgeny V. Brenner, Anastasia A. Hodkevich, Victoria V. Dzyubenko, Sergey E. Krasilnikov, Alphiya S. Mansurova, Irina E. Vakhturova, et al. "Cervicovaginal-Microbiome Analysis by 16S Sequencing and Real-Time PCR in Patients from Novosibirsk (Russia) with Cervical Lesions and Several Years after Cancer Treatment." Diagnostics 13, no. 1 (January 1, 2023): 140. http://dx.doi.org/10.3390/diagnostics13010140.

Full text
Abstract:
Disturbed cervicovaginal-microbiome (CVM) structure promotes human papillomavirus (HPV) persistence and reflects risks of cervical lesions and cancer onset and recurrence. Therefore, microbiomic biomarkers may be useful for cervical disease screening and patient management. Here, by 16S rRNA gene sequencing and commercial PCR-based diagnostic kits, we profiled CVM in cytological preparations from 140 HPV-tested women (from Novosibirsk, Russia) with normal cytological findings, cervical lesions, or cancer and from 101 women who had recently received different cancer therapies. An increase in lesion severity was accompanied by higher HPV prevalence and elevated CVM biodiversity. Post-treatment CVM was found to be enriched with well-known microbial biomarkers of dysbiosis, just as in cervical disease. Nonetheless, concentrations of some skin-borne and environmental species (which gradually increased with increasing lesion severity)—especially Cutibacterium spp., Achromobacter spp., and Ralstonia pickettii—was low in post-treatment patients and depended on treatment types. Frequency of Lactobacillus iners dominance was high in all groups and depended on treatment types in post-treatment patients. Microbiome analysis via PCR-based kits revealed statistically significant differences among all groups of patients. Thus, microbiome profiling may help to find diagnostic and prognostic markers for management of cervical lesions; quantitative PCR-based kits may be suitable for these purposes.
APA, Harvard, Vancouver, ISO, and other styles
6

Kyongo, Jordan K., Tania Crucitti, Joris Menten, Liselotte Hardy, Piet Cools, Johan Michiels, Sinead Delany-Moretlwe, et al. "Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention." Clinical and Vaccine Immunology 22, no. 5 (March 11, 2015): 526–38. http://dx.doi.org/10.1128/cvi.00762-14.

Full text
Abstract:
ABSTRACTData on immune mediators in the genital tract and the factors that modulate them in sub-Saharan women are limited. Cervicovaginal lavage (CVL) samples from 430 sexually active women from Kenya, South Africa, and Rwanda were analyzed for 12 soluble immune mediators using Bio-Plex and Meso Scale Discovery multiplex platforms, as well as single enzyme-linked immunosorbent assays. Ten bacterial species were quantified in vaginal swab samples. Bacterial vaginosis (BV) was defined by Nugent scoring. CVL samples from HIV-infected women showed a clear-cut proinflammatory profile. Pregnant women, adolescents, and women engaging in traditional vaginal practices differed in specific soluble markers compared to reference groups of adult HIV-negative women. Cervical mucus, cervical ectopy, abnormal vaginal discharge, and having multiple sex partners were each associated with an increase in inflammatory mediators. The levels of interleukin-1α (IL-1α), IL-1β, IL-6, IL-12(p70), and IL-8 were elevated, whereas the IL-1RA/IL-1(α+β) ratio decreased in women with BV. The level of gamma interferon-induced protein 10 was lower in BV-positive than in BV-negative women, suggesting its suppression as a potential immune evasion mechanism by BV-associated bacteria.Lactobacillus crispatusandLactobacillus vaginaliswere associated with decreased proinflammatory cytokines and each BV-associated species with increased proinflammatory cytokines. Remarkably, thein vitroanti-HIV activity of CVL samples from BV-positive women was stronger than that of BV-negative women. In conclusion, we found significant associations of factors, including vaginal microbiota, which can influence immune mediators in the vaginal environment in sexually active women. These factors need to be considered when establishing normative levels or pathogenic cutoffs of biomarkers of inflammation and associated risks in African women.
APA, Harvard, Vancouver, ISO, and other styles
7

Nunn, Kenetta L., Ying-Ying Wang, Dimple Harit, Michael S. Humphrys, Bing Ma, Richard Cone, Jacques Ravel, and Samuel K. Lai. "Enhanced Trapping of HIV-1 by Human Cervicovaginal Mucus Is Associated with Lactobacillus crispatus-Dominant Microbiota." mBio 6, no. 5 (October 6, 2015). http://dx.doi.org/10.1128/mbio.01084-15.

Full text
Abstract:
ABSTRACTCervicovaginal mucus (CVM) can provide a barrier that precludes HIV and other sexually transmitted virions from reaching target cells in the vaginal epithelium, thereby preventing or reducing infections. However, the barrier properties of CVM differ from woman to woman, and the causes of these variations are not yet well understood. Using high-resolution particle tracking of fluorescent HIV-1 pseudoviruses, we found that neither pH nor Nugent scores nor total lactic acid levels correlated significantly with virus trapping in unmodified CVM from diverse donors. Surprisingly, HIV-1 was generally trapped in CVM with relatively high concentrations ofd-lactic acid and aLactobacillus crispatus-dominant microbiota. In contrast, a substantial fraction of HIV-1 virions diffused rapidly through CVM with low concentrations ofd-lactic acid that had aLactobacillus iners-dominant microbiota or significant amounts ofGardnerella vaginalis, a bacterium associated with bacterial vaginosis. Our results demonstrate that the vaginal microbiota, including specific species ofLactobacillus, can alter the diffusional barrier properties of CVM against HIV and likely other sexually transmitted viruses and that these microbiota-associated changes may account in part for the elevated risks of HIV acquisition linked to bacterial vaginosis or intermediate vaginal microbiota.IMPORTANCEVariations in the vaginal microbiota, especially shifts away fromLactobacillus-dominant microbiota, are associated with differential risks of acquiring HIV or other sexually transmitted infections. However, emerging evidence suggests thatLactobacillus inersfrequently colonizes women with recurring bacterial vaginosis, raising the possibility thatL. inersmay not be as protective as otherLactobacillusspecies. Our study was designed to improve understanding of how the cervicovaginal mucus barrier against HIV may vary between women along with the vaginal microbiota and led to the finding that the vaginal microbiota, including specific species ofLactobacillus, can directly alter the diffusional barrier properties of cervicovaginal mucus. This work advances our understanding of the complex barrier properties of mucus and highlights the differential protective ability of different species ofLactobacillus, withLactobacillus crispatusand possibly other species playing a key role in protection against HIV and other sexually transmitted infections. These findings could lead to the development of novel strategies to protect women against HIV.
APA, Harvard, Vancouver, ISO, and other styles
8

Guo, Chunlei, Wenkui Dai, Qian Zhou, Liming Gui, Han Cai, Di Wu, Jun Hou, et al. "Cervicovaginal microbiota significantly changed for HPV-positive women with high-grade squamous intraepithelial lesion." Frontiers in Cellular and Infection Microbiology 12 (August 4, 2022). http://dx.doi.org/10.3389/fcimb.2022.973875.

Full text
Abstract:
Lower female genital tract is colonized by a variety of microbes (cervicovaginal microbiota, CVM) which associate with the risk of genital infection. This study characterized CVM for 149 Chinese women with different status of human papillomavirus (HPV) infection and squamous intraepithelial lesion (SIL): no HPV infection (HPV-), HPV infection without significant SIL (HPV+NoSIL), HPV infection with low-grade SIL (HPV+LSIL) and HPV infection with high-grade SIL (HPV+HSIL). Analysis results showed CVM has dramatically changed in HPV+HSIL group when compared to HPV+LSIL group, but it exhibited no significant differences between HPV- and HPV+NoSIL groups as well as between HPV+NoSIL and HPV+LSIL groups. In consistence, random forest analysis found more notable differences in HPV+HSIL vs HPV+LSIL comparison than in other comparisons. In addition, depletion of Lactobacillus in CVM was more to be frequently identified in SIL-positive women as compared to SIL-negative individuals. Our findings suggested that significant CVM differences occurred when SIL developed to HSIL which was caused by persistent HPV infection.
APA, Harvard, Vancouver, ISO, and other styles
9

Witkin, Steven S., and Iara M. Linhares. "HIV Inhibition by Lactobacilli: Easier in a Test Tube Than in Real Life." mBio 6, no. 5 (October 6, 2015). http://dx.doi.org/10.1128/mbio.01485-15.

Full text
Abstract:
ABSTRACT A lactobacillus-dominant vaginal microbiota has been shown to decrease heterosexual HIV transmission. Nunn et al. now report that a vaginal microbiota dominated by Lactobacillus crispatus is associated with a relative inability of HIV pseudoviral particles to transverse cervicovaginal mucus (CVM) in vitro [mBio 6(5):e01084-15, 2015, doi:10.1128/mBio.01084-15]. The purported inhibitory mechanism is the interaction between carboxyl groups present on HIV and in CVM that occurred only under acidic conditions when carboxyl groups were protonated. L. crispatus produces high levels of lactic acid and results in the lowest vaginal pH when it is the dominant vaginal bacterium. In addition, high levels of lactic acid inhibit the proliferation of other bacteria that might negatively affect CVM structure. The utility of enhancing L. crispatus dominance to inhibit HIV transmission awaits assessment of the influence of ejaculated semen on this property and investigations on the role of Lactobacillus products such as d-lactic acid in this property.
APA, Harvard, Vancouver, ISO, and other styles
10

Dai, Wenkui, Hui Du, Shuaicheng Li, and Ruifang Wu. "Cervicovaginal Microbiome Factors in Clearance of Human Papillomavirus Infection." Frontiers in Oncology 11 (July 28, 2021). http://dx.doi.org/10.3389/fonc.2021.722639.

Full text
Abstract:
Persistent high-risk human papillomavirus (hrHPV) infection is the highest risk to cervical cancer which is the fourth most common cancer in women worldwide. A growing body of literatures demonstrate the role of cervicovaginal microbiome (CVM) in hrHPV susceptibility and clearance, suggesting the promise of CVM-targeted interventions in protecting against or eliminating HPV infection. Nevertheless, the CVM-HPV-host interactions are largely unknown. In this review, we summarize imbalanced CVM in HPV-positive women, with or without cervical diseases, and the progress of exploring CVM resources in HPV clearance. In addition, microbe- and host-microbe interactions in HPV infection and elimination are reviewed to understand the role of CVM in remission of HPV infection. Lastly, the feasibility of CVM-modulated and -derived products in promoting HPV clearance is discussed. Information in this article will provide valuable reference for researchers interested in cervical cancer prevention and therapy.
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "CVM (cervicovaginal microbiota)"

1

Nicolo', Sabrina. "Interplay among microbial communities, epithelial cells, and immune system in vaginal mucosa of women with high-risk Human Papillomavirus infection." Doctoral thesis, 2022. http://hdl.handle.net/2158/1275958.

Full text
Abstract:
Persistent infection with HR-HPVs is a primary cause of cervical cancer worldwide. Among HR-HPV, subtypes HPV-16 and HPV-18 are most associated with invasive cancers and are thought to cause approximately 65-75% of cases. Emerging evidence indicates that CVM plays a substantial role in the viral persistence and subsequent disease. Accordingly, a role of CVM composition in the regression of high grade of CIN lesions has been reported. Data from clinical studies show that Lactobacillus-dominated cervicovaginal microbiota and L. crispatus particularly was positively associated with the clearance of the virus and negatively associated with the neoplastic progression of intraepithelial lesions. In contrast, vaginal-dysbiosis associated bacteria were correlated with the persistence of HR-HPVs infection and with increasing cancer risk. The molecular mechanisms based on such effects are not elucidated yet. Aim of this study was to investigate whether each vaginal bacterial species, commonly found in cervicovaginal microbial communities, may affect the expression of viral oncogenes and accelerate the neoplastic transformation of HR-HPV transformed cells. For this purpose, the HPV-16 transformed SiHa epithelial cells (with ~1,2 copies of integrated viral genome) were selected as experimental model of CIN-1 and bacterial strains, representatives of the 5 CSTs, were evaluated for their effect on the expression of viral oncogenic proteins E6 and E7, the fate of cellular oncosuppressor protein p53, the effects on cell survival/growth of HPV-transformed SiHa cells, and the synthesis of matrix-degrading enzymes. Our data show that G. vaginalis and M. micronuciformis directly induce the expression of the viral E6 and E7 oncogenes and the synthesis of the respective products by SiHa cells. These bacteria also induce the expression of E6-AP, a ubiquitin protein ligase that binds to E6 and induce p53 degradation. As consequence of E6 activation and p53 degradation, cell proliferation is increased. L. crispatus never induces the expression of viral oncogenes or proteins, while L. iners and L. jensenii slightly induce the viral E7 gene -4- expression but not E6. In contrast to G. vaginalis or M. micronuciformis, vaginal Lactobacilli did not affect the cell cycle of cervical epithelial cells. G. vaginalis and M. micronuciformis also induce high expression of MMP-9, a cellular protein which overexpression has been observed in different malignant tumors. All these data were obtained by using live bacterial cells, supernatants, or bacterial lysates. Supernatants from bacterial culture are not effective in the system suggesting the responsivity of very labile or not secreted products. Although not all strains of G. vaginalis have the same property to induce the expression of viral oncogenes and oncoproteins, our data strongly suggest that this species together with M. micronuciformis may play an important role in neoplastic transformation of HR-HPV infected cell. According with data from clinical data, the presence of G. vaginalis or M. micronuciformis in the vaginal fluid of women with persistent HR-HPV infection or CIN-1 should direct these groups to a close follow-up or to surgical excision respectively. Abbreviations: HR-HPV (High-Risk Human Papillomavirus), CVM (cervicovaginal microbiota), CST (community state type), CIN (cervical intraepithelial neoplasia), CIN-1 (low grade of cervical intraepithelial neoplasia), E6-AP (E6-Associated Protein), L. (Lactobacillus), G. (Gardnerella), M. (Megasphaera), MMP-9 (Matrix Metalloproteinase-9).
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography